Business Description
Caplin Point Laboratories Ltd
ISIN : INE475E01026
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 215.19 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 560.43 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 21.17 | |||||
Beneish M-Score | -1.92 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.1 | |||||
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 21.2 | |||||
3-Year Book Growth Rate | 29 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.49 | |||||
9-Day RSI | 37.33 | |||||
14-Day RSI | 40.83 | |||||
6-1 Month Momentum % | 9.93 | |||||
12-1 Month Momentum % | 92.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.67 | |||||
Quick Ratio | 4.53 | |||||
Cash Ratio | 2.47 | |||||
Days Inventory | 157.96 | |||||
Days Sales Outstanding | 91.34 | |||||
Days Payable | 87.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.35 | |||||
Dividend Payout Ratio | 0.08 | |||||
3-Year Dividend Growth Rate | -2.4 | |||||
Forward Dividend Yield % | 0.39 | |||||
5-Year Yield-on-Cost % | 0.6 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.33 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.48 | |||||
Operating Margin % | 29.57 | |||||
Net Margin % | 26.85 | |||||
FCF Margin % | 4.78 | |||||
ROE % | 23.28 | |||||
ROA % | 19.82 | |||||
ROIC % | 30.01 | |||||
ROC (Joel Greenblatt) % | 52.78 | |||||
ROCE % | 28.25 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.92 | |||||
PE Ratio without NRI | 22.92 | |||||
Shiller PE Ratio | 42.63 | |||||
Price-to-Owner-Earnings | 36.18 | |||||
PEG Ratio | 1.2 | |||||
PS Ratio | 6.15 | |||||
PB Ratio | 4.83 | |||||
Price-to-Tangible-Book | 4.71 | |||||
Price-to-Free-Cash-Flow | 129.43 | |||||
Price-to-Operating-Cash-Flow | 37.11 | |||||
EV-to-EBIT | 16.56 | |||||
EV-to-EBITDA | 15.23 | |||||
EV-to-Revenue | 5.53 | |||||
EV-to-FCF | 117.32 | |||||
Price-to-Projected-FCF | 3.62 | |||||
Price-to-DCF (Earnings Based) | 0.93 | |||||
Price-to-DCF (FCF Based) | 13.55 | |||||
Price-to-Median-PS-Value | 1.21 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
Price-to-Graham-Number | 2.21 | |||||
Price-to-Net-Current-Asset-Value | 7.32 | |||||
Price-to-Net-Cash | 25.06 | |||||
Earnings Yield (Greenblatt) % | 6.04 | |||||
FCF Yield % | 0.8 | |||||
Forward Rate of Return (Yacktman) % | 19.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Caplin Point Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 16,301.6 | ||
EPS (TTM) (₹) | 57.496 | ||
Beta | 0.83 | ||
Volatility % | 30.81 | ||
14-Day RSI | 40.83 | ||
14-Day ATR (₹) | 44.767448 | ||
20-Day SMA (₹) | 1317.3325 | ||
12-1 Month Momentum % | 92.92 | ||
52-Week Range (₹) | 676.7 - 1617.8 | ||
Shares Outstanding (Mil) | 75.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Caplin Point Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Caplin Point Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Caplin Point Laboratories Ltd Frequently Asked Questions
What is Caplin Point Laboratories Ltd(BOM:524742)'s stock price today?
When is next earnings date of Caplin Point Laboratories Ltd(BOM:524742)?
Does Caplin Point Laboratories Ltd(BOM:524742) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |